...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of health communication >Do Prescription Drug Ads Tell Consumers Enough About Benefits and Side Effects? Results From the Health Information National Trends Survey, Fourth Administration
【24h】

Do Prescription Drug Ads Tell Consumers Enough About Benefits and Side Effects? Results From the Health Information National Trends Survey, Fourth Administration

机译：处方药广告能否告诉消费者足够的好处和副作用？第四届政府卫生信息全国趋势调查的结果

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Direct-to-consumer prescription drug advertising (DTCA) is a major source of consumer information about prescription drugs. The present study updates 2002 U.S. Food and Drug Administration phone survey questions that found that 44% and 61% of consumers thought that DTCA did not include enough information about benefits and risks, respectively. The present study was administered by mail using a nationally representative sample, and provides a more in-depth understanding of how these beliefs relate to demographic and health characteristics. Data collected from 3,959 respondents to the National Cancer Institute's 2011 Health Information National Trends Survey find results similar to the 2002 survey: 46% and 52% of respondents thought that DCTA did not include enough information about benefits and risks, respectively. Respondents fell into four groups: 23% agreed that DTCA tells enough about drug benefits and risks, 41% disagreed, 18% expressed no opinion, and 18% had discordant beliefs. DTCA attitudes were negatively associated with education, income, and whether respondents purchase prescription drugs; attitudes were positively associated with whether respondents understand prescription drug information. This study confirms that a plurality of Americans believe that DTCA does not include enough information about benefits and risks, suggesting that the educational effect of DTCA could be improved.
机译：面向消费者的处方药广告（DTCA）是有关处方药的消费者信息的主要来源。本研究更新了2002年美国食品药品监督管理局的电话调查问题，发现44％和61％的消费者认为DTCA分别没有包含有关收益和风险的足够信息。本研究使用具有全国代表性的样本通过邮寄方式进行，对这些信念与人口统计和健康特征之间的关系提供了更深入的了解。从美国国家癌症研究所2011年健康信息国家趋势调查的3959名受访者收集的数据中得出的结果与2002年的调查相似：46％和52％的受访者认为DCTA分别没有包含足够的收益和风险信息。受访者分为四类：23％的人同意DTCA充分说明了药物的益处和风险，41％的人不同意，18％的人没有意见，18％的人持不一致的信念。 DTCA的态度与教育程度，收入以及受访者是否购买处方药负相关;态度与受访者是否了解处方药信息成正相关。这项研究证实，许多美国人认为DTCA并未包含有关收益和风险的足够信息，这表明DTCA的教育效果可以得到改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号